Lv1
80 积分 2025-04-16 加入
A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity
2个月前
已关闭
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study
3个月前
已完结
Safety and Efficacy of Intensive BP Control in Cardiovascular-Kidney-Metabolic Syndrome: A Post Hoc Analysis of the SPRINT Trial
4个月前
已关闭
Identifying potential drugs for treating Cardiovascular-kidney metabolic syndrome via reverse network pharmacology
4个月前
已关闭
METTL3 inhibitor STM2457 impairs tumor progression and enhances sensitivity to anlotinib in OSCC
5个月前
已完结
Development and Validation of the American Heart Association’s PREVENT Equations
5个月前
已完结
Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
6个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease
6个月前
已完结
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population
6个月前
已完结
Risk assessment with gut microbiome and metabolite markers in NAFLD development
6个月前
已完结
皖公网安备34019202002308
